Allergy/Asthma News

The LIBERTY ASTHMA VOYAGE trial of dupilumab met its primary and key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate to severe asthma, according to a press release.

Inhalation parameters recorded by a digital asthma device can be used to indicate inhaler technique deterioration, which often wanes soon after patients receive training, researchers reported at the virtual CHEST Annual Meeting.

Record high temperatures and raging wildfires, which are currently occurring in California and the western United States, can create dangerous air quality and serious health hazards for people with and without preexisting medical conditions.

The earlier introduction of white children to peanuts, milk and eggs compared with Black children may contribute to racial differences in food allergy prevalence, according to findings presented at the AAP National Conference & Exhibition.

Multilevel home and school asthma education improved asthma control and reduced oral corticosteroid use and hospitalizations among children in a low-income community setting, according to new data published in JAMA Pediatrics.

Adherence to a high-fiber diet may aid in mediating systemic inflammation and decrease the risk for respiratory morbidity, including asthma, according to study results published in the Annals of the American Thoracic Society.

A composite type-2 biomarker corticosteroid adjustment strategy did not result in a greater proportion of patients with severe asthma reducing their corticosteroid dose, according to results published in The Lancet Respiratory Medicine.

Long-term treatment with dupilumab shows sustained improvement in lung function and reduction in severe exacerbations in patients with moderate to severe asthma, according to new results from a phase 3, open-label extension trial.

Early exposure to high levels of air pollution may be associated with reduced lung function during adolescence, researchers reported at the virtual European Respiratory Society International Congress.

Personalized medicine with genotype-based prescribing of asthma controller medication led to improvement quality of life for young people with asthma compared with standard care, according to new research.